CRXL (Crucell NV)
All Pro Portfolios with CRXL
All Do-It-Yourself Portfolios with CRXL
- Total Do-It-Yourself Portfolios with CRXL:
- ed Portfolio 2
- Speculative JS
- Forego Funds
- bolsman1
- Hollis - Scaggs
- jbonwow Portfolio 1
- Rolling the Dice on Bird Flu Stocks -- One Year Later
- nytebyrd's foreign equities 5-16-07
- Groninga
- framur Portfolio 1
- 085241618 Portfolio 1
- jjmp Portfolio 1
- EDSDUCK&COVER
- Behind the Headlines 1
- Fast Money's Swine Flu Stock Plays
- M&A Monday
- show more
- 31
- shrivastav Portfolio 1
- CDP Portfolio1
- Four Biotechs to watch
- JAK
- Items I Own
- WallyOne
- Bird Flu
- claudecaruana Portfolio 1
- Stockerblog.com Dutch Stocks
- dnnlgallion Portfolio 1
- dogsrus Portfolio 1
- Biotechnological box of tricks
- Jay28w Portfolio
- Fast Money's Rising Stock Stars
- RAPTOR LAST 4
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
Date:09 28 09 |
|
"Johnson & Johnson (JNJ) has purchased 14.6 million shares of Dutch biotech company Crucell (CRXL) for 301.8 million euros ($441 million)." Read more here. |
|
Not yet rated
Rate now:
|
|
By:barrons3 |
Date:04 29 09 |
On the vaccine side, companies like GlaxoSmithKline, Baxter(BAX) and Crucell(CRXL) stand to benefit, he said. |
|
Not yet rated
Rate now:
|
|
By:Dr Ed |
Date:10 16 08 |
OLD HOLDING |
|
Not yet rated
Rate now:
|
|
By:Dr Ed |
Date:10 16 08 |
OLD HOLDING |
|
Not yet rated
Rate now:
|
|
By:Dr Ed |
Date:10 16 08 |
OLD HOLDING |
|
Not yet rated
Rate now:
|
|
By:flosz |
Date:04 12 08 |
Per.c6/STAR |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:06 23 07 |
negative earnings |
|
Not yet rated
Rate now:
|
|
By:pickr007 |
Date:05 08 07 |
PER.C6 tech used by Sanofi in H5N1 vaccine development |
|
Not yet rated
Rate now:
|
|
By:sarah z |
Date:05 03 07 |
PER.C6 tech used by Sanofi in H5N1 vaccine development |
|
Not yet rated
Rate now:
|
|
By:wallisweaver |
Date:04 27 07 |
Good pipeline and technology |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |
